KellyElizabethMcCannMDPhD
Oncology • Santa Monica, CABreast Cancer, Cancer Genetics/Cancer Risk Assessment
Assistant Clinical Professor
Dr. McCann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2336 Santa Monica Blvd., Suite 304
Santa Monica, CA 90404Phone+1 310-998-4747Fax+1 310-998-4747
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2011 - 2014
Stanford University School of MedicineClass of 2011, MD, PhD
Certifications & Licensure
OR State Medical License 2013 - Present
CA State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 54 citationsAdvances in Targeted Therapies for Triple-Negative Breast Cancer.Kelly E McCann, Sara A. Hurvitz, Nicholas P. McAndrew
Drugs. 2019-07-01 - 12 citationsNovel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer.Kelly E McCann
Current Opinion in Obstetrics & Gynecology. 2017-12-01 - 87 citationsAdvances in the use of PARP inhibitor therapy for breast cancer.Kelly E McCann, Sara A. Hurvitz
Drugs in Context. 2018-08-08
Press Mentions
Why More Women Are Living with Stage 4 Breast CancerOctober 28th, 2023- Clinical Challenges: Managing Toxicities of Newer Breast Cancer TherapiesNovember 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
